Telesis Bio Inc
NASDAQ:TBIO 9:35:28 AM EDT
| Market Cap (Intraday) | 31.72M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.13 |
| 50-Day MA | $1.29 |
| 200-Day MA | $1.80 |
Telesis Bio Inc Stock, NASDAQ:TBIO
10431 Wateridge Circle, Suite 150, San Diego, California 92121-2993
United States of America
Phone: +1.858.228.4115
Number of Employees: 243
Description
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.